Time to buy? Sunny Agrawal finds best picks across banking, pharma, capital markets & infrastructureIndian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...
MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...
MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
MNC pharma: Time to relook at them? 8 pharma stocks, 4 with an upside potential of between 16 and 47%In the past four years, several MNC pharma companies announced the sale of a part of their businesses in India. Some of this was part of gl...
Will they get back the lost shine? 5 MNC pharma stocks with upside potential of up to 21%There was a time when having MNC stock was a must have in one's portfolio. They reason, they were very liberal at giving bonuses, dividend ...
Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
Will MNC pharma stocks get back their mojo for good or is it just a blip?Most of the MNC pharma companies have formed their subsidiary and a large majority of new drugs launched in India were via this route. This...
Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...
Not the time for bottom fishing, you may catch falling knives: Ajay BaggaBear markets see sharp rallies. It is still time to stay on the sidelines, says the market expert.
Stick to MNC pharma stocks on multi-year basis: Ajay BaggaIndependent market expert Ajay Bagga says Indian pharma companies do not invest enough into the quality assurance and are driven by promote...
Aurobindo Pharma eyes European business of ApotexThe deal may be valued at around $100 million and fits in with Aurobindo’s strategic road map of upping its presence in eastern Europe thro...
Invest 15-20% of your portfolio in select pharma stocks; MNCs can be better betsClinton is generally perceived to be negative for pharma companies on the premise that she would try to curb the profits earned by the drug...
Underweight on MNC pharma stocks, prefer domestic companies: Pramerica MF"The focus is more on domestic pharma company which have a base in domestic market as well as they have base," Mantri said.
- Extremely bullish on MNC pharma space: Angel Broking
Opportunity in the pharma industry is huge so probably these parent companies may get more serious because they have been so far not taking...
- Investors queue up for MNC pharma companies; GlaxoSmithKline Pharma, Pfizer rise
Investors were seen flocking to the counters of select MNC pharma companies which have emerged as defensive bets amid choppy market conditi...
- Bullish on MNC pharma stocks: Rajen Shah
"Well if you see MNC pharma stocks, I am bullish on MNC pharma stocks like Wyeth, Merck, Pfizer and Novartis. "
- MNC pharma firms told to launch latest drugs in India
The government has asked MNC pharma companies to launch latest drugs in India.